Methyl 1,2,3,4-tetrahydroacridine-9-carboxylate, 95+%, 100mg

4-Hydroxybenzotrifluoride, 98.0%, 10g

3-Bromo-2-oxo-butyric acid ethyl ester, 95.0%, 2.5g

tert-Butyl cis-4-(methylamino)cyclohexyl)carbamate, 95, 100mg

(S)-1-Methyl-piperidin-3-ylamine dihydrochloride, 97.0%, 250mg

1-Bromo-3-isopropylbenzene, 95.0%, 25g

N-(2-ACETYLPHENYL)-4-METHYLPENTANAMIDE, 95.0%, 500mg

6-Methyl-pyrazolo[1,5- a ]pyrimidine-3-carboxylic acid, 95.0%, 10g

5-Chloro-N-(2,4-dimethoxybenzyl)-2,4-difluoro-N-(5-fluorothiazol-2-yl)benzenesulfonamide, 96%, 250mg

4-Methoxy-3-[(pyridin-3-ylmethyl)-amino]-benzoic acid, 97%, 2g

5-Cyclopropyl-1,3,4-oxadiazole-2-carbaldehyde, 100mg

2-(Azetidin-3-yloxy)-6-methoxypyridine, 98%, 50mg

Polvo de tungsteno, mínimo 99 %, aproximadamente malla 325, 50 g, envase de plástico.